marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 31.10.2024
Syros Pharmaceuticals Bilanz 2011-2024 | SYRS
Bilanz Jährlich Syros Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-103 M | -125 M | -50.3 M | -133 M | -15.5 M | -49.9 M | -32.2 M | -58.4 M | -35.6 M | -60.4 M | - | - | - |
Langfristige Schulden |
34.6 M | 40.6 M | 40.3 M | 39.6 M | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
2.32 M | 2.01 M | 1.72 M | 1.46 M | 1.04 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 47.3 M | 8.65 M | 751 K | 1.15 M | 1.63 M | 1 K | - | - | - |
Kurzfristige Verbindlichkeiten |
36.7 M | 30.8 M | 31.5 M | 28.6 M | 23.5 M | 19.5 M | 12.4 M | 9.57 M | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | - | - | 70.8 M | 28.2 M | 13.2 M | 10.7 M | 9.58 M | 1.25 M | - | - | - |
Aufgeschobenes Einkommen |
- | 4.33 M | 10.2 M | 12.2 M | 5.74 M | 1.93 M | - | 550 K | - | - | - | - | - |
Gewinnrücklagen |
-723 M | -558 M | -464 M | -377 M | -293 M | -218 M | -155 M | -101 M | -53.5 M | -23.7 M | - | - | - |
Vermögenswerte |
168 M | 244 M | 183 M | 213 M | 150 M | 107 M | 78.5 M | 91.3 M | 43.6 M | 61.5 M | - | - | - |
Zahlungsmittel |
140 M | 167 M | 92.3 M | 174 M | 41.4 M | 49.9 M | 32.2 M | 58.6 M | 35.9 M | 60.4 M | - | - | - |
Buchwert |
168 M | 244 M | 183 M | 213 M | 79.2 M | 78.6 M | 65.3 M | 80.6 M | 34 M | 60.2 M | - | - | - |
Gesamtes Eigenkapital |
16.7 M | 128 M | 85.2 M | 90.6 M | 79.2 M | 78.6 M | 65.3 M | 80.6 M | -48 M | -21.8 M | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Syros Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
41.1 M | 40.9 M | 29.7 M | 34.6 M | 39.4 M | 40.9 M | 39.1 M | 40.6 M | 40.5 M | 34 M | 38.8 M | 40.3 M | 40.1 M | 39.9 M | 39.7 M | 39.6 M | 39.6 M | 39.6 M | 39.6 M | 621 K | 621 K | 621 K | 621 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | 139 K | 2.18 M | 3.24 M | 4.33 M | 1.62 M | 3.59 M | 7.77 M | 10.2 M | 12 M | 12.1 M | 12.8 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 5.74 M | 5.74 M | 5.74 M | 5.74 M | 1.93 M | 1.93 M | 1.93 M | 1.93 M | - | - | - | - | 550 K | 550 K | 550 K | 550 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-756 M | -750 M | -727 M | -723 M | -658 M | -618 M | -582 M | -558 M | -553 M | -523 M | -489 M | -464 M | -440 M | -414 M | -391 M | -377 M | -377 M | -377 M | -377 M | -293 M | -293 M | -293 M | -293 M | -218 M | -218 M | -218 M | -218 M | -155 M | -155 M | -155 M | -155 M | -101 M | -101 M | -101 M | -101 M | -53.5 M | -53.5 M | -53.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
85 M | 107 M | 135 M | 168 M | 148 M | 181 M | 205 M | 244 M | 285 M | 126 M | 152 M | 183 M | 208 M | 234 M | 261 M | 213 M | 213 M | 213 M | 213 M | 150 M | 150 M | 150 M | 150 M | 107 M | 107 M | 107 M | 107 M | 78.5 M | 78.5 M | 78.5 M | 78.5 M | 91.3 M | 91.3 M | 91.3 M | 91.3 M | 43.6 M | 43.6 M | 43.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
58.3 M | 79 M | 83.5 M | 140 M | 112 M | 115 M | 105 M | 167 M | 172 M | 59.1 M | 69.6 M | 92.3 M | 119 M | 164 M | 222 M | 177 M | 174 M | 174 M | 174 M | 41.4 M | 41.4 M | 41.4 M | 41.4 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 58.6 M | 58.6 M | 58.6 M | 58.6 M | 35.9 M | 35.9 M | 35.9 M | - | 60.4 M | - | - | - | 3.8 M | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
85 M | 107 M | 135 M | 168 M | 148 M | 181 M | 205 M | 244 M | 285 M | 126 M | 152 M | 183 M | 208 M | 234 M | 261 M | 213 M | 213 M | 213 M | 213 M | 150 M | 150 M | 150 M | 150 M | 107 M | 107 M | 107 M | 107 M | 78.5 M | 78.5 M | 78.5 M | 78.5 M | 91.3 M | 91.3 M | 91.3 M | 91.3 M | 43.6 M | 43.6 M | 43.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
-11.1 M | -6.35 M | 15.1 M | 16.7 M | 36.3 M | 73.2 M | 107 M | 128 M | 129 M | 31 M | 62.7 M | 85.2 M | 106 M | 130 M | 150 M | 90.6 M | 90.6 M | 90.6 M | 90.6 M | 79.2 M | 79.2 M | 79.2 M | 79.2 M | 78.6 M | 78.6 M | 78.6 M | 78.6 M | 65.3 M | 65.3 M | 65.3 M | 65.3 M | 80.6 M | 80.6 M | 80.6 M | 80.6 M | -48 M | -48 M | -48 M | - | -21.8 M | - | - | - | -9.29 M | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung